86 related articles for article (PubMed ID: 6180584)
1. Effect of dextran on the fibrinolytic activity of urokinase.
Matsuo O; Kosugi T; Mihara H
Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):112-8. PubMed ID: 6180584
[No Abstract] [Full Text] [Related]
2. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
Matsuo O; Kawaguchi T; Kosugi T; Mihara H
Thromb Res; 1978 Dec; 13(6):1125-30. PubMed ID: 749265
[No Abstract] [Full Text] [Related]
3. [Experimental studies on thrombolytic agents. (1) Comparison between prostaglandin E1, heparin and urokinase (author's transl)].
Suzuki T; Takano S
Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):890-6. PubMed ID: 735704
[No Abstract] [Full Text] [Related]
4. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
Takada Y; Takada A
Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
[No Abstract] [Full Text] [Related]
5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
6. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
7. [Pharmacology of fibrinolytics].
Klöcking HP
Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination treatment with mitomycin-c and lysosome labilizers on nodular pulmonary metastases.
Niitani H; Suzuki A; Taniguchi T; Saijo N; Kawase I; Kimura K
Gan; 1974 Oct; 65(5):403-9. PubMed ID: 4279834
[No Abstract] [Full Text] [Related]
9. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
10. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
11. Synergism of thrombolytic agents: investigational procedures and clinical potential.
Collen D
Circulation; 1988 Apr; 77(4):731-5. PubMed ID: 3127075
[No Abstract] [Full Text] [Related]
12. Antithrombogenicity of immobilized urokinase and its clinical significance.
Sugitachi A; Kawahara T; Kodama J; Kikkawa Y; Takagi K
Blut; 1978 Jul; 37(1):31-6. PubMed ID: 667367
[TBL] [Abstract][Full Text] [Related]
13. [Heparin and urokinase interactions in the fibrinolytic system].
Villaverde CA; Badimón L; Badimón JJ; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):268-9. PubMed ID: 397804
[No Abstract] [Full Text] [Related]
14. Assessment of the thrombolytic effect of low urokinase concentrations.
Matsuo O; Mihara H; Rokushima Y
Nihon Ketsueki Gakkai Zasshi; 1976 Jun; 39(3):298-305. PubMed ID: 990007
[No Abstract] [Full Text] [Related]
15. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits.
Hisano S; Sueishi K; Ishii Y; Tanaka K
Thromb Haemost; 1979 Jun; 41(4):796-803. PubMed ID: 483251
[TBL] [Abstract][Full Text] [Related]
16. [Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo].
Badimón L; Villaverde CA; Vidal M; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):262-4. PubMed ID: 397803
[No Abstract] [Full Text] [Related]
17. [The thrombolytic action of urokinase enhanced by prostaglandin E1 in vitro].
Ma CJ
Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):355-6. PubMed ID: 1307973
[No Abstract] [Full Text] [Related]
18. Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Juhan-Vague I; Stassen JM; Alessi MC; Elias A; Aillaud MF; Serradimigni A; Collen D
Semin Thromb Hemost; 1989 Oct; 15(4):390-4. PubMed ID: 2554499
[No Abstract] [Full Text] [Related]
19. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
Ueno T; Kobayashi N; Maekawa T
Thromb Haemost; 1979 Oct; 42(3):885-94. PubMed ID: 505403
[TBL] [Abstract][Full Text] [Related]
20. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
Brochier M; Griguer P
Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
